Oragenics, Inc. (OGEN) Earnings History
Annual and quarterly earnings data from 2003 to 2025
Loading earnings history...
OGEN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
OGEN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export OGEN earnings history in CSV or JSON format
Free sign-in required to download data
Oragenics, Inc. (OGEN) Earnings Overview
As of May 8, 2026, Oragenics, Inc. (OGEN) reported trailing twelve-month net income of -$10M, reflecting -185.0% year-over-year growth. The company earned $-2.30 per diluted share over the past four quarters.
Looking at the long-term picture, OGEN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2003.
Oragenics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SIGA (-$4.04T net income, 24.6% margin), ADMA ($165M net income, 28.8% margin), NVAX (-$88M net income, 39.2% margin), OGEN has comparable earnings metrics. Compare OGEN vs SIGA →
OGEN Earnings vs Peers
Earnings metrics vs comparable public companies
OGEN Historical Earnings Data (2003–2025)
23 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$9.84B | -93035.5% | -$9M | $-4.56 | - | - |
| 2024 | -$11M | +48.8% | -$11M | $-1.60 | - | - |
| 2023 | -$21M | -44.6% | -$21M | $-9.18 | - | - |
| 2022 | -$14M | +9.1% | -$14M | $-7.11 | - | - |
| 2021 | -$16M | +40.6% | -$16M | $-8.09 | - | - |
| 2020 | -$26M | -69.7% | -$27M | $-28.05 | - | - |
| 2019 | -$16M | -57.1% | -$16M | $-22.10 | - | - |
| 2018 | -$10M | -47.3% | -$10M | $-45.62 | - | - |
| 2017 | -$7M | +4.0% | -$7M | $-81.99 | - | - |
| 2016 | -$7M | +40.1% | -$9M | $-94.33 | - | - |
See OGEN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OGEN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OGEN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOGEN — Frequently Asked Questions
Quick answers to the most common questions about buying OGEN stock.
Is OGEN growing earnings?
OGEN EPS fell to $-2.30, with earnings declining -185.0%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-10M.
What are OGEN's profit margins?
Oragenics, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are OGEN's earnings?
OGEN earnings data spans 2003-2025. The declining earnings trend is -185.0% YoY. Historical data enables comparison across business cycles.